CXCR4 and acute lymphoblastic leukemia: Habringer at al. (137) recently reported that endoradiotherapy with 177Lu-pentixather effectively targeted CXCR4+ tumor cells and significantly reduced leukemic burden in patient-derived and cell-line-based models of T-ALL and AML.